Active-ingredient Dossier
Dexamethasone
Active-ingredient Dossier for Dexamethasone (corticosteroid). Australian brands, products, PBS listings, PBAC outcomes — compiled by arcimedes.
- Brand: DEXMETHSONE
- Brand: OZURDEX
- Brand: MAXIDEX
- Brand: OTODEX
- Brand: SOFRADEX
- Therapeutic area: Ophthalmology
- Therapeutic area: Immunology
- Therapeutic area: Other
What is
Dexamethasone Dexamethasone is a corticosteroid.
Australian brands containing
Dexamethasone — DEXMETHSONE — OZURDEX — MAXIDEX — OTODEX — SOFRADEX
Therapeutic areas
Dexamethasone is registered across multiple therapeutic areas. Ophthalmology accounts for 2 brands, oncology for 1 brand, infectious disease for 1 brand, and other therapeutic areas for 1 brand.
Sponsor landscape
Four sponsors market dexamethasone in Australia: Pharmaco, Aspen Pharmacare, Novartis Pharmaceuticals, and AbbVie.
PBS and regulatory activity
Two brands containing dexamethasone have PBS-listed items, with the latest PBS schedule date being 1 May 2026. The latest PBAC outcome was recorded on 1 March 2018, and the latest AusPAR was published on 6 June 2017.